Meta-Analysis to Assess the Quality of Warfarin Control in Atrial Fibrillation Patients in the United States

BACKGROUND: Atrial fibrillation (AF) affects a significant proportion of the American population and increases ischemic stroke risk by 4- to 5-fold. Oral vitamin K antagonists, such as warfarin, can significantly reduce this stroke risk but can be difficult to dose and monitor. Previous research on...

Descripción completa

Detalles Bibliográficos
Autores principales: Baker, William L., Cios, Deborah A., Sander, Stephen D., Coleman, Craig I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437339/
https://www.ncbi.nlm.nih.gov/pubmed/19326955
http://dx.doi.org/10.18553/jmcp.2009.15.3.244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437339/
https://www.ncbi.nlm.nih.gov/pubmed/19326955
http://dx.doi.org/10.18553/jmcp.2009.15.3.244

Ejemplares similares